The trademark TRIGELAN was filed by G.L. Pharma GmbH, a corporation established under the laws of the Republic of Austria (the "Applicant"). The application was published for oppositions on July 24, 2024, and received one opposition filed on October 20, 2024 by BIOFARMA on Likelihood of confusion. the opponent was represented by CABINET GERMAIN & MAUREAU and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 20, 2024
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).